Classification of transdermaldrug delivery systemslideshare The development of effective protein and peptide drug delivery systems is crucial for harnessing the therapeutic potential of these biomolecules. Proteins and peptides, while offering high efficacy and lower toxicity compared to traditional chemical drugs, face significant challenges in their delivery due to their inherent instability, large molecular size, and susceptibility to enzymatic degradation. This presentation explores the landscape of protein and peptide drug delivery, highlighting key advancements, formulation strategies, and the ongoing quest for improved drug delivery systems that overcome these obstacles.Protein Drug Delivery System - PPT
Proteins and peptides are complex macromolecules that play vital roles in biological processesIn this review, three typical design strategies ofself-assembled peptide nanomaterials for drug deliveryhave been summarized.. As therapeutic agents, they offer targeted action and reduced side effectsProtein and peptide drugs have to be delivered by injection. 3. Why do we need NDDS? The conventional dosage forms provide drug release immediately and it .... However, their journey from administration to the target site is fraught with difficulties.作者：PP Nugrahadi·2023·被引用次数：74—Whileproteinsusually act as structural and regulatory molecules [9],peptidesregulate a broad spectrum of biological effects, includingproteins[10,11]. The primary hurdle is their susceptibility to degradation by proteases in the gastrointestinal tract, rendering oral administration largely ineffective for many of these drugs. Furthermore, their large size can impede absorption across biological membranes.Basics and recent advances in peptide and protein drug delivery Consequently, the parenteral route (eThe document discussesprotein and peptide drug delivery systems, outlining the types of proteins, their functions, and the barriers to protein drug delivery..g.Protein and Peptide Drug Delivery, injection) has historically been the most efficient way for systemic delivery of proteins and peptides. This necessitates frequent injections, impacting patient compliance and quality of lifeProtein and peptide drugs have to be delivered by injection. 3. Why do we need NDDS? The conventional dosage forms provide drug release immediately and it ....
To address these limitations, significant research has focused on developing novel drug delivery systems (DDS) that can protect proteins and peptides from degradation, enhance their absorption, and enable alternative routes of administrationAdvances in nanoscale carrier-based approaches to .... These advancements often leverage various technologies:
* Nanocarrier-Based Systems: Nanocarrier-based protein/peptide (P/P) delivery systems are emerging as a promising avenue. These include liposomes, polymeric nanoparticles, and micelles, which encapsulate the therapeutic protein or peptide, shielding it from the harsh biological environment. These carriers can also be engineered to target specific tissues or cells, further improving therapeutic outcomes and reducing off-target effects2026年1月13日—Design, Formulation and Testing of Systemically Dosed Peptideand Polymer DNA and. mRNA Nanoparticles - Design, Formulation and Testing of .... This approach is particularly being explored for pulmonary drug delivery and crossing the blood-brain barrierAdvances in nanoscale carrier-based approaches to ....
* Self-Assembled Peptide Nanomaterials: Self-assembled peptide nanomaterials offer unique drug delivery capabilities. These systems are formed from peptides that spontaneously assemble into ordered nanostructures, creating a matrix for drug loading and controlled releaseNovel Drug Delivery System. Their biocompatibility and biodegradability make them attractive candidates for therapeutic applications.
* Polymer-Based Systems: Various reservoir-based polymer drug delivery systems and other polymer matrices are designed for sustained or controlled release of proteins and peptides.Reservoir-Based Polymer Drug Delivery Systems These can include biodegradable polymers that gradually degrade, releasing the encapsulated drug over an extended period.
* Lipid-Based Formulations: Multifunctional self-emulsifying drug delivery systems and other lipid-based formulations are being investigated for their potential to improve the solubility and oral bioavailability of peptide and protein drugs.2012年1月11日—Presentation Transcript. 1.Protein Drug Delivery SystemTeam Members: Austin Ramme- Team Leader Michael Haggerty- BSAC Andrew Neumann- BWIG ...
Beyond parenteral administration, considerable effort is directed towards developing non-invasive routes for protein and peptide drug delivery.
* Oral Delivery: While challenging, advancements in oral and transdermal peptide drug delivery are being made.2024年3月22日—➢Parenteral route is most efficient way for systemic delivery of proteins and peptides. ➢ This is the best choice to achieve therapeutic ... This involves strategies like enteric coatings, permeation enhancers, and enzyme inhibitors to protect the drugs in the GI tract and facilitate their absorption.
* Transdermal Delivery: Transdermal drug delivery systems offer a needle-free alternative. Techniques such as microneedles, iontophoresis, and penetration enhancers are being explored to facilitate the passage of proteins and peptides across the skin作者：J Yan·2019·被引用次数：143—Thisreviewfocuses on the origin, structural characteristics, action and potential mechanisms of anti-diabeticpeptideson the key enzymes andproteinsin ....
* Pulmonary Delivery: The lungs provide a large surface area and rich vasculature, making them an attractive route for systemic delivery of macromolecules. Inhaled protein and peptide formulations can offer rapid absorption and bypass first-pass metabolism.
The success of any protein and peptide drug delivery system hinges on meticulous formulation and evaluation. Key considerations include ensuring the stability and integrity of the protein or peptide during formulation and storage, achieving the desired release profile, and demonstrating efficacy and safety in preclinical and clinical studies. Techniques for evaluating these systems involve assessing drug loading efficiency, release kinetics, stability under various conditions, pharmacokinetic profiles, and ultimately, therapeutic effectiveness作者：C Zhang·2023·被引用次数：24—The nano-baseddrug deliveryplatform has been introduced toPPT deliveryfor the purpose of improved solubility, enhanced efficacy, and reduced toxicity..
The field of protein and peptide drug delivery is continuously evolving. Future research is likely to focus on developing even more sophisticated delivery platforms, including smart drug delivery systems that respond to physiological cues, enhanced targeting strategies, and combination therapies.In this review, three typical design strategies ofself-assembled peptide nanomaterials for drug deliveryhave been summarized. The ultimate goal is to make protein and peptide therapies more accessible, convenient, and effective for a wider range of diseasesFormulation and evaluation of protein drug delivery system..
Join the newsletter to receive news, updates, new products and freebies in your inbox.